Glenn Sblendorio - Sep 13, 2023 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
Director
Signature
/s/ Adam Levy, Attorney-in-fact
Stock symbol
MLYS
Transactions as of
Sep 13, 2023
Transactions value $
$0
Form type
4
Date filed
9/14/2023, 04:13 PM
Previous filing
Jul 13, 2023
Next filing
Nov 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLYS Stock Option Award $0 +44K $0.00 44K Sep 13, 2023 Common Stock 44K $12.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in 36 monthly installments beginning on October 13, 2023.